Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.

Vormittag, L; Lemaire, C; Radonjic, D; Kornek, G; Selzer, E

Vormittag, L; Lemaire, C; Radonjic, D; Kornek, G; Selzer, E.

Affiliation

Vormittag L; Division of Clinical Oncology, Department of Medicine I and Cancer Center, Medical University Vienna, Vienna, Austria.

Strahlenther Onkol ; 188(3): 235-42, 2012 Mar.

Article in En | MEDLINE | ID: mdl-22318328

Subject(s)

Antimetabolites, Antineoplastic/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Carcinoma, Squamous Cell/radiotherapy; Deoxycytidine/analogs & derivatives; Fluorouracil/analogs & derivatives; Head and Neck Neoplasms/drug therapy; Head and Neck Neoplasms/radiotherapy; Adult; Aged; Capecitabine; Carcinoma, Squamous Cell/mortality; Combined Modality Therapy/adverse effects; Deoxycytidine/therapeutic use; Female; Fluorouracil/therapeutic use; Head and Neck Neoplasms/mortality; Humans; Male; Middle Aged; Mucositis/etiology; Neoplasm Recurrence, Local/drug therapy; Neoplasm Recurrence, Local/radiotherapy; Radiotherapy/adverse effects; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Deoxycytidine / Fluorouracil / Head and Neck Neoplasms / Antimetabolites, Antineoplastic Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Strahlenther Onkol Year: 2012 Document type: Article

Fulltext

XML

PubMed Links

Search on Google